INS and type 1 diabetes mellitus: Approximately one-fifth of people living with T1DM are in low-and lower-middle-income countries (LMICs) based on modeling from 201 countries using 2021 data [1], and individuals in these countries have substantially worse outcomes due to limited access to insulin, supplies, and skilled care.